![](https://endpts.com/wp-content/uploads/2023/11/Fran-Crawford.jpg)
Fran Crawford, ViaNautis CEO
UCB, Eli Lilly-backed ViaNautis raises $25M in Series A to develop genetic nanomedicines
UK-based biotech ViaNautis Bio has bagged $25 million in a Series A round supported by two Big Pharma companies to advance its nanomedicine technology with …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.